New challenges in the treatment of early breast cancer or surgery for early breast cancer ... can less be more?
Breast cancer is a major public health problem of great interest and importance to physicians in a variety of specialities. The incidence of the disease has increased dramatically, heightening concern among physicians and women in general. In addition, long-term results are now available from clinical trials initiated in the 1970s and 1980s to evaluate the usefulness of early detection with mammography and physical examination, breast-conserving treatment with limited breast surgery and irradiation, and adjuvant systemic therapy with hormonal therapy and chemotherapy. Furthermore, in the light of newly gained knowledge, new strategies for addressing this problems have been proposed. In this review, we will summarize the evidence evaluating the strategies for diagnosis and therapy initiated in the 1970s and 1980s, and will describe the prospects for prevention and for more specific treatments bases on evolving biologic knowledge. Our review will only focus on early breast cancer, discussing the following topics: Breast Cancer screening: Who should be screened and how often?; New technologies in Breast Cancer Diagnosis; Selection of patients for Breast-conserving therapy; Management of the axilla in primary breast cancer or "Is sentinel lymph node biopsy useful?"; Expanded use of adjuvant systemic therapy; Genetic predisposition for Breast Cancer; Clinical options for Women at high-risk for Breast Cancer.
Meurisse
M
M
Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Liège, Belgium. MIC.Meurisse@chu.ulg.ac.be
Defechereux
Th
T
Meurisse
N
N
Bataille
Y
Y
Hamoir
E
E
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000601:surgery*; D005260:Female; D006801:Humans; D013997:Time Factors